Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Antithrombotic activity of kininogen is mediated by inhibitory effects of domain 3 during arterial injury in vivo.

Antithrombotic activity of kininogen is mediated by inhibitory effects of domain 3 during arterial injury in vivo. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Antithrombotic activity of kininogen is mediated by inhibitory effects of domain 3 during arterial injury in vivo. Abstract Text:

    sarmina hassanSarmina Hassan,irma m sainzIrma M Sainz,mohammad m khanMohammad M Khan,harlan n bradfordHarlan N Bradford,irma isordia-salasIrma Isordia-Salas,sakeen w kashemSakeen W Kashem,r balfour sartorR Balfour Sartor,robert w colmanRobert W Colman,

    High-molecular-weight kininogen (HK) and its domain 3 (D3) exhibit anticoagulant properties and inhibit platelet activation at low thrombin concentration in vitro. We hypothesized that the rapid occlusive thrombosis in HK-deficient (HKd) rats following endothelial injury of the aorta results from enhanced platelet aggregation by thrombin. The effects of D3 (G235-M357) or D3-derived peptides on thrombosis in vivo were tested. D3 and its exon 7C terminal peptide (E7CP, K270-Q292), expressed as glutathione S-transferase (GST) fusion proteins (GST-D3, GST-E7CP), or GST alone, as well as cleaved HK (HKa) or synthetic peptide E7CP, were infused intravenously 10 min before endothelial injury. Blood flow was reduced down to 10% of baseline flow within 28 +/- 5.2 min by a platelet-fibrin thrombus in GST-treated HKd rats compared with >240 min in GST-treated normal HK rats (wild type). GST-D3, GST-E7CP, HKa, or E7CP infusion prolonged the flow time to 233, >240, 223, and >240 min, respectively, in HKd rats. When GST-E7CP was infused 10 min after the injury, blood flow was maintained for >240 min. Thrombin-antithrombin concentrations were elevated by injury in HKd rats receiving GST from 35 to 55 microg/l and decreased with GST-E7CP, HKa, or E7CP reconstitution to 40, 15, and 9 microg/l, respectively. We conclude that HKd rats are prothrombotic and that HKa, kininogen D3, and its fragment E7CP modulate arterial thrombosis after endothelial injury.

    Antithrombotic activity of kininogen is mediated by inhibitory effects of domain 3 during arterial injury in vivo. Publishing Authors By Initials

    s hassanS Hassan,im sainzIM Sainz,mm khanMM Khan,hn bradfordHN Bradford,i isordia-salasI Isordia-Salas,sw kashemSW Kashem,rb sartorRB Sartor,rw colmanRW Colman,

    For similar cardiovascular diseases: vascular diseases: embolism and thrombosis: thrombosis research abstracts see: cardiovascular diseases: vascular diseases: embolism and thrombosis: thrombosis research

    PUBMED ID PMID:

    MEDLINE DATE:

    Antithrombotic activity of kininogen is mediated by inhibitory effects of domain 3 during arterial injury in vivo. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: American journal of physiology. Heart and circulat

    VOLUME: 292

    Page Numbers: H2959-65

    Journal Abbreviation: Am. J. Physiol. Heart Circ. Ph

    ISSN: 0363-6135

    DAY: 9

    MONTH: 02

    YEAR: 2007

    Antithrombotic activity of kininogen is mediated by inhibitory effects of domain 3 during arterial injury in vivo. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 100901228

    Antithrombotic activity of kininogen is mediated by inhibitory effects of domain 3 during arterial injury in vivo. Keywords Mesh Terms:

    KEYWORDS: Thrombosis

    MESH TERMS: prevention & control

    Chemical & Substance for Abstract: Antithrombotic activity of kininogen is mediated by inhibitory effects of domain 3 during arterial injury in vivo. Information

    Substance Name: Thrombin

    Registry Number: EC 3.4.21.5

    Grant and Affiliation Information for Antithrombotic activity of kininogen is mediated by inhibitory effects of domain 3 during arterial injury in vivo.

    AFFILIATION: Sol Sherry Thrombosis Research Center, Temple Univeristy School of Medicine, 3400 N. Broad St., Rm. 418 OMS, Philadelphia, PA 19140, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NHLBI

    GRANT: T32 HL0077713

    ACRONYM: HL

    MEDLINETA: Am J Physiol Heart Circ Physio

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Antithrombotic activity of kininogen is mediated by inhibitory effects of domain 3 during arterial injury in vivo Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News